Source: Eur Respir J, 54 (6) 1902098; 10.1183/13993003.02098-2019
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Suzanne Crowley, Kai-Håkon Carlsen. Tracheomalacia and bronchomalacia in children: response to the ERS statement. Eur Respir J, 54 (6) 1902098; 10.1183/13993003.02098-2019

Member's Comments

No comment yet.

Related content which might interest you: Key messages from the ERS statement on tracheobronchomalacia in children Source: International Congress 2019 – Tracheobronchomalacia in children Year: 2019 ERS statement: interventional bronchoscopy in children Source: Guideline 2017 Year: 2017 ERS statement: interventional bronchoscopy in children Source: Eur Respir J, 50 (6) 1700901; 10.1183/13993003.00901-2017 Year: 2017 ERS Statement on Tracheomalacia and Bronchomalacia in Children Source: Guideline 2019 Year: 2019 ERS statement on protracted bacterial bronchitis in children Source: Eur Respir J, 50 (2) 1602139; 10.1183/13993003.02139-2016 Year: 2017 ERS statement on protracted bacterial bronchitis in children Source: Guideline 2017 Year: 2017 ERS clinical practice guidelines on bronchiectasis in children Source: ERS webinar 2021: ERS clinical practice guidelines on bronchiectasis in children Year: 2021 ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax Source: Eur Respir J 2015; 46: 321-335 Year: 2015 Asthma diagnosis and reversible airway obstruction in adults in Poland – results from the BOLD study Source: Annual Congress 2008 - Asthma and miscellaneous disorders Year: 2008 Management of children and adolescents with bronchiectasis: summary of the ERS clinical practice guideline Source: Breathe, 17 (3) 210105; 10.1183/20734735.0105-2021 Year: 2021 Wheezing, stridor and obstruction of the left main bronchus in a 2-year-old boy: a diagnostic dilemma Source: Annual Congress 2008 - Paediatric Grand Round - an interactive session Year: 2008 ERS guidelines on the diagnosis and treatment of chronic cough in adults and children Source: Eur Respir J, 55 (1) 1901136; 10.1183/13993003.01136-2019 Year: 2020 ERS task force on definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep: statement presentation Source: International Congress 2016 – ERS statements and technical standards Year: 2016 ERJ November Podcast: ERS statement on the diagnosis and treatment of pulmonary disease caused by a1-antitrypsin deficiency Source: Eur Respir J, 50 (5) 17E5005; 10.1183/13993003.E5005-2017 Year: 2017 Airway disease and inhaled corticosteroids (ICS) in children with primary ciliary dyskinesia (PCD) Source: International Congress 2016 – Paediatric respiratory infection Year: 2016 ERS statement on obstructive sleep disordered breathing in 1- to 23-month-old children Source: Guideline 2017 Year: 2017 ERS statement on obstructive sleep disordered breathing in 1- to 23-month-old children Source: Eur Respir J, 50 (6) 1700985; 10.1183/13993003.00985-2017 Year: 2017 ERS statement on obstructive sleep disordered breathing in 1- to 23-month-old children Source: Guideline 2017 Year: 2017 Clinical follow-up in children with laryngomalacia Source: International Congress 2015 – Paediatric bronchology Year: 2015